Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Nov. 15, 2021 XCUR A 7,500 $0.91 $6,825 15,000 Direct +100.00% Acquired -99.2% (price as of 2026-10-02)
May 14, 2021 XCUR A 7,500 $1.27 $9,525 7,500 Direct · Acquired -99.4% (price as of 2026-10-02)
April 27, 2021 XCUR A 220,000 · · 220,000 Direct · Acquired (price as of 2026-10-02)
June 3, 2020 XCUR A 400,000 · · 400,000 Direct · Acquired (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
April 27, 2021 XCUR Employee Stock Option (right to buy) Common Stock (220,000) $1.90 April 26, 2031 220,000 Acquired
June 3, 2020 XCUR Employee Stock Option (right to buy) Common Stock (400,000) $2.72 June 2, 2030 400,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

XCUR

M.D.(11) Former Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2020 $239,882 · · $770,480 $63,480 · · $1,073,842

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.